Ramona Schulz‐Heddergott

783 total citations
15 papers, 531 citations indexed

About

Ramona Schulz‐Heddergott is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Ramona Schulz‐Heddergott has authored 15 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Ramona Schulz‐Heddergott's work include Cancer-related Molecular Pathways (7 papers), Heat shock proteins research (4 papers) and DNA Repair Mechanisms (3 papers). Ramona Schulz‐Heddergott is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Heat shock proteins research (4 papers) and DNA Repair Mechanisms (3 papers). Ramona Schulz‐Heddergott collaborates with scholars based in Germany, United States and France. Ramona Schulz‐Heddergott's co-authors include Ute M. Moll, Matthias Dobbelstein, Lena‐Christin Conradi, Hanibal Bohnenberger, Jinyu Li, Shelley J. Edmunds, Fatih Ceteci, Florian R. Greten, Evguenia M. Alexandrova and Natalia Marchenko and has published in prestigious journals such as Nature Communications, Blood and Cancer Cell.

In The Last Decade

Ramona Schulz‐Heddergott

13 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ramona Schulz‐Heddergott Germany	8	339	288	143	64	54	15	531
Shohei Kishishita United States	5	449 1.3×	223 0.8×	103 0.7×	54 0.8×	48 0.9×	8	578
Tim Hoey United States	7	408 1.2×	456 1.6×	182 1.3×	63 1.0×	36 0.7×	23	685
Benjamin L. Bryson United States	12	354 1.0×	287 1.0×	150 1.0×	98 1.5×	50 0.9×	17	584
Valeria Capaci Italy	8	426 1.3×	235 0.8×	196 1.4×	55 0.9×	23 0.4×	15	554
Llorenç Coll-Mulet Spain	11	452 1.3×	263 0.9×	93 0.7×	90 1.4×	67 1.2×	12	663
Jee‐Heun Kim South Korea	7	280 0.8×	202 0.7×	132 0.9×	49 0.8×	68 1.3×	10	451
Hind Hafsi France	10	385 1.1×	301 1.0×	93 0.7×	50 0.8×	21 0.4×	12	524
Dorine Bellanger France	11	330 1.0×	201 0.7×	199 1.4×	103 1.6×	55 1.0×	15	586
Catherine A. Vaughan United States	14	355 1.0×	330 1.1×	121 0.8×	57 0.9×	22 0.4×	21	552
Diana Spiegelberg Sweden	14	308 0.9×	279 1.0×	93 0.7×	62 1.0×	19 0.4×	31	555

Countries citing papers authored by Ramona Schulz‐Heddergott

Since Specialization

Citations

This map shows the geographic impact of Ramona Schulz‐Heddergott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramona Schulz‐Heddergott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramona Schulz‐Heddergott more than expected).

Fields of papers citing papers by Ramona Schulz‐Heddergott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramona Schulz‐Heddergott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramona Schulz‐Heddergott. The network helps show where Ramona Schulz‐Heddergott may publish in the future.

Co-authorship network of co-authors of Ramona Schulz‐Heddergott

This figure shows the co-authorship network connecting the top 25 collaborators of Ramona Schulz‐Heddergott. A scholar is included among the top collaborators of Ramona Schulz‐Heddergott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramona Schulz‐Heddergott. Ramona Schulz‐Heddergott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Küffer, Stefan, Lukas Klein, Christof Lenz, et al.. (2025). TP53 missense–specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. Science Advances. 11(27). eadu2339–eadu2339.

Wegwitz, Florian, Tiago De Oliveira, Lena‐Christin Conradi, et al.. (2025). Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition. Cell Death and Differentiation. 32(9). 1734–1749. 5 indexed citations

Bucala, Richard, et al.. (2025). Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer. Oncogenesis. 14(1). 30–30.

Mamone, Salvatore, et al.. (2024). Real‐Time Metabolic Magnetic Resonance Spectroscopy of Pancreatic and Colon Cancer Tumor‐Xenografts with Parahydrogen Hyperpolarized 1‐¹³C Pyruvate‐d₃. Chemistry - A European Journal. 30(51). e202400187–e202400187. 3 indexed citations

Bagger, Frederik Otzen, Jonathan Séguin, Matheus Filgueira Bezerra, et al.. (2023). The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53. Blood. 141(18). 2245–2260. 4 indexed citations

Dickmanns, Antje, et al.. (2023). CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan. Cell Cycle. 22(13). 1563–1582. 1 indexed citations

Neeße, Albrecht, et al.. (2021). Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity. Nature Communications. 12(1). 4019–4019. 15 indexed citations

Singh, Shiv K., et al.. (2021). The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells. Frontiers in Oncology. 11. 642603–642603. 29 indexed citations

Oliveira, Tiago De, et al.. (2021). Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer. Cell Death and Disease. 12(2). 155–155. 60 indexed citations

10.

Bagger, Frederik Otzen, Matheus Filgueira Bezerra, Sabine Juge, et al.. (2019). Transformation Mechanisms of the Nfia-ETO2 Fusion Gene Associated with Pediatric Pure Acute Erythroleukemia. Blood. 134(Supplement_1). 532–532. 2 indexed citations

11.

Schulz‐Heddergott, Ramona, Shelley J. Edmunds, Jinyu Li, et al.. (2018). Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion. Cancer Cell. 34(2). 298–314.e7. 181 indexed citations

12.

Schulz‐Heddergott, Ramona & Ute M. Moll. (2018). Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target. Cancers. 10(6). 188–188. 81 indexed citations

13.

Alexandrova, Evguenia M., et al.. (2017). p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo. Cell Death and Disease. 8(3). e2661–e2661. 75 indexed citations

14.

Wienken, Magdalena, et al.. (2016). p53 Activity Results in DNA Replication Fork Processivity. Cell Reports. 17(7). 1845–1857. 57 indexed citations

15.

Kramer, Daniela, Ramona Schulz‐Heddergott, Shelley J. Edmunds, et al.. (2016). Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells. Cell Death and Differentiation. 24(2). 300–316. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact